Consumer Brands · NYSE: PG
Procter & Gamble earnings: results, call transcripts & KPI history
2 quarters · fiscal year ends June · next results expected around 21 Jan 2027
Latest: Q1 FY2027
P&G reported fiscal 2027 first quarter net sales of $23.3 billion, up four percent, with organic sales up four percent, diluted EPS of $1.97 and Core EPS of $2.00, each up one percent.
Procter & Gamble's July-September quarter brought net sales of $23.3 billion, up four percent, and organic sales also up four percent. Volume grew two percent and mix one percent, and every category and region grew. Diluted EPS was $1.97 and Core EPS was $2.00, each up one percent. Higher commodity costs and product reinvestments cut core gross margin by 150 basis points. Free cash flow productivity was 93%, and $3.9 billion was returned to shareowners.
Quarters
KPI history
Fourth quarter worked out from the annual figure.
Data
| Q2 FY25 | $21.9B |
| Q3 FY25 | $19.8B |
| Q4 FY25 | $20.9B * |
| Q1 FY26 | $22.4B |
| Q2 FY26 | $22.2B |
| Q3 FY26 | $21.2B |
| Q4 FY26 | $21.2B * |
| Q1 FY27 | $23.3B |
Data
| Q2 FY25 | $1.88 |
| Q3 FY25 | $1.54 |
| Q1 FY26 | $1.95 |
| Q2 FY26 | $1.78 |
| Q3 FY26 | $1.63 |
| Q1 FY27 | $1.97 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q2 FY25 | 26.2% |
| Q3 FY25 | 23.0% |
| Q4 FY25 | 20.8% |
| Q1 FY26 | 26.2% |
| Q2 FY26 | 24.2% |
| Q3 FY26 | 21.5% |
| Q4 FY26 | 18.6% |
| Q1 FY27 | 25.5% |
Data
| Q2 FY25 | $3.9B |
| Q3 FY25 | $2.8B |
| Q4 FY25 | $4.0B |
| Q1 FY26 | $4.2B |
| Q2 FY26 | $3.8B |
| Q3 FY26 | $3.0B |
| Q4 FY26 | $4.1B |
| Q1 FY27 | $4.4B |
Operating cash flow minus capital expenditure, from cash flow statements.
| Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.9B | $19.8B | $20.9Bd | $22.4B | $22.2B | $21.2B | $21.2Bd | $23.3B |
| Operating income | $5.7B | $4.6B | $4.4Bd | $5.9B | $5.4B | $4.6B | $4.0Bd | $5.9B |
| Operating margin | 26.2% | 23.0% | 20.8% | 26.2% | 24.2% | 21.5% | 18.6% | 25.5% |
| Net income | $4.6B | $3.8B | $3.6Bd | $4.8B | $4.3B | $3.9B | $3.0Bd | $4.7B |
| Diluted EPS | $1.88 | $1.54 | — | $1.95 | $1.78 | $1.63 | — | $1.97 |
| Operating cash flow | $4.8Bd | $3.7Bd | $5.0Bd | $5.4B | $5.0Bd | $4.0Bd | $5.1Bd | $5.8B |
| Capital expenditure | $925.0Md | $859.0Md | $996.0Md | $1.2B | $1.2Bd | $1.0Bd | $1.0Bd | $1.4B |
| Free cash flow | $3.9B | $2.8B | $4.0B | $4.2B | $3.8B | $3.0B | $4.1B | $4.4B |
From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.
10-Q and 10-K filings
- 22 Oct 202610-Q for the period ended 30 Sep 2026SEC ↗
- 4 Aug 202610-K for the period ended 30 Jun 2026SEC ↗
- 24 Apr 202610-Q for the period ended 31 Mar 2026SEC ↗
- 23 Jan 202610-Q for the period ended 31 Dec 2025SEC ↗
- 24 Oct 202510-Q for the period ended 30 Sep 2025SEC ↗
- 4 Aug 202510-K for the period ended 30 Jun 2025SEC ↗
- 24 Apr 202510-Q for the period ended 31 Mar 2025SEC ↗
- 22 Jan 202510-Q for the period ended 31 Dec 2024SEC ↗